Biocon Limited has acquired an equity stake in Ampin C&I Power Twelve Private Limited (AMPIN), a Special Purpose Vehicle established for solar power generation and supply. This strategic acquisition, valued at Rs. 5,47,60,000, aligns with Biocon’s renewable energy objectives, aiming to support green energy procurement and advance decarbonization goals. The investment is expected to reduce the company’s energy costs and carbon footprint.
Biocon Secures Stake in Renewable Energy Venture
Biocon Limited announced on June 10, 2026, its acquisition of an equity stake in Ampin C&I Power Twelve Private Limited (AMPIN). AMPIN is a Special Purpose Vehicle (SPV) established with the primary objective of generating and supplying solar power. This strategic move underscores Biocon’s commitment to enhancing its renewable energy consumption and supporting its broader sustainability initiatives.
Investment Details and Strategic Rationale
The company has invested Rs. 5,47,60,000 (Rupees Five Crores Forty Seven Lakhs Sixty Thousand only) towards the subscription of 54,76,000 equity shares of AMPIN. The face value of each share is Rs. 10. This investment is expected to secure Biocon’s captive power status as per the Electricity Act. Furthermore, the acquisition aligns with Biocon’s renewable energy objectives, supporting the procurement of green energy, advancing decarbonization goals, and ultimately reducing energy costs and carbon footprint.
AMPIN’s Project and Future Shareholding
AMPIN is set to establish a Solar Power Plant with a significant capacity of 27.12 MW (DC) in the state of Karnataka. The newly incorporated company, AMPIN, was registered on April 23, 2025. Following the current investment, Biocon will hold 59,76,000 Equity shares, representing 37.77% of AMPIN’s paid-up share capital. It is noted that post-investment by other entities in AMPIN, Biocon’s stake is projected to reduce to 15.91% of the paid-up share capital on a fully diluted basis.
Financial Snapshot of AMPIN
As of March 31, 2026, AMPIN reported a net worth of Rs. 120.78 million. For the financial year 2025-26, AMPIN’s standalone turnover was NIL, and its Profit After Tax (PAT) was a loss of Rs. (1.28) million. Given its recent incorporation, the turnover for the last three years is not applicable.
Transaction Compliance
This acquisition is confirmed not to fall within related party transactions, and neither the promoter nor the promoter group of Biocon Limited has any interest in AMPIN. The transaction is conducted at arm’s length, adhering to all necessary regulatory guidelines.
Source: BSE
